Literature DB >> 16951933

Idiopathic membranous nephropathy in children.

Beom Hee Lee1, Hee Yeon Cho, Hee Gyung Kang, Il Soo Ha, Hae Il Cheong, Kyung Chul Moon, In Seok Lim, Yong Choi.   

Abstract

Idiopathic membranous nephropathy (MN) is a rare cause of asymptomatic proteinuria (AP) or nephrotic syndrome (NS) in childhood. To improve our understanding of its clinical course, we retrospectively reviewed 19 cases of idiopathic MN seen in our hospital over a period of 28.5 years, i.e., from January 1977 to July 2005. Eight patients (39%) had AP and 11 (61%) presented with NS. All eight AP patients achieved remission, regardless of treatment modality. Oral corticosteroid was given to all 11 NS patients, but only three of them responded to corticosteroid. Of the eight steroid non-responders, three achieved remissions with the addition of cyclosporine, and the five who were not administered additional immunosuppressive drugs had persistent NS. At the latest evaluation, all six NS patients that achieved remission remained free of proteinuria and had a normal renal function. Moreover, two of the 5 steroid non-responders showed persistent nephrotic-range proteinuria but a stable renal function. The remaining three steroid non-responders progressed into chronic renal insufficiency, and this progression was preceded by renal vein thrombosis (RVT) in two of the three patients. Presentation with NS (P=0.045) and the development of RVT (P=0.010) were identified as poor prognostic factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951933     DOI: 10.1007/s00467-006-0246-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  30 in total

1.  Idiopathic membranous nephropathy in children.

Authors:  H Olbing; I Greifer; B P Bennett; J Bernstein; A Spitzer
Journal:  Kidney Int       Date:  1973-06       Impact factor: 10.612

2.  A renal biopsy study of hepatitis B virus-associated nephropathy in Korea.

Authors:  H S Lee; Y Choi; S H Yu; H I Koh; M J Kim; K W Ko
Journal:  Kidney Int       Date:  1988-10       Impact factor: 10.612

3.  Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.

Authors:  D C Cattran; G B Appel; L A Hebert; L G Hunsicker; M A Pohl; W E Hoy; D R Maxwell; C L Kunis
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

4.  A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Altieri; F Scolari; P Passerini; D Roccatello; B Cesana; P Melis; B Valzorio; M Sasdelli; S Pasquali; C Pozzi; G Piccoli; A Lupo; S Segagni; F Antonucci; M Dugo; M Minari; A Scalia; L Pedrini; G Pisano; C Grassi; M Farina; R Bellazzi
Journal:  J Am Soc Nephrol       Date:  1998-03       Impact factor: 10.121

5.  The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party.

Authors:  J S Cameron; M J Healy; D Adu
Journal:  Q J Med       Date:  1990-02

Review 6.  Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review.

Authors:  Annalisa Perna; Arrigo Schieppati; Javier Zamora; Giovanni A Giuliano; Norbert Braun; Giuseppe Remuzzi
Journal:  Am J Kidney Dis       Date:  2004-09       Impact factor: 8.860

7.  Idiopathic membranous glomerulopathy in Canadian children: a clinicopathologic study.

Authors:  P Latham; S Poucell; A Koresaar; G Arbus; R Baumal
Journal:  J Pediatr       Date:  1982-11       Impact factor: 4.406

8.  Comparison of idiopathic and systemic lupus erythematosus-associated membranous glomerulonephropathy in children. The Southwest Pediatric Nephrology Study Group.

Authors: 
Journal:  Am J Kidney Dis       Date:  1986-02       Impact factor: 8.860

9.  A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; P Passerini; L Cagnoli; B Cesana; C Pozzi; S Pasquali; E Imbasciati; C Grassi; B Redaelli
Journal:  N Engl J Med       Date:  1989-01-05       Impact factor: 91.245

10.  Prognosis of untreated patients with idiopathic membranous nephropathy.

Authors:  A Schieppati; L Mosconi; A Perna; G Mecca; T Bertani; S Garattini; G Remuzzi
Journal:  N Engl J Med       Date:  1993-07-08       Impact factor: 91.245

View more
  11 in total

1.  Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy.

Authors:  Bizhen Zhu; Jianping Huang
Journal:  Pediatr Nephrol       Date:  2010-10-29       Impact factor: 3.714

Review 2.  Evolution of antiglomerular basement membrane glomerulonephritis into membranous glomerulonephritis.

Authors:  Natalie Hecht; Abiodun Omoloja; Dave Witte; Leonardo Canessa
Journal:  Pediatr Nephrol       Date:  2007-11-13       Impact factor: 3.714

3.  Membranous glomerulonephritis: treatment response and outcome in children.

Authors:  Rudolph P Valentini; Tej K Mattoo; Gaurav Kapur; Abubakr Imam
Journal:  Pediatr Nephrol       Date:  2008-10-10       Impact factor: 3.714

4.  An unusual case of loin pain and nephritis.

Authors:  Alison Lap-tak Ma; Wai-ming Lai; Man-chun Chiu
Journal:  Clin Exp Nephrol       Date:  2009-10-03       Impact factor: 2.801

5.  Idiopathic membranous nephropathy associated with polycystic kidney disease.

Authors:  Severin Kengne-Wafo; Laura Massella; Francesca Diomedi-Camassei; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2009-12-22       Impact factor: 3.714

6.  Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN).

Authors:  Michelle M O'Shaughnessy; Jonathan P Troost; Andrew S Bomback; Michelle A Hladunewich; Isa F Ashoor; Keisha L Gibson; Raed Bou Matar; David T Selewski; Tarak Srivastava; Michelle N Rheault; Amira Al-Uzri; Amy J Kogon; Myda Khalid; Suzanne Vento; Neil S Sanghani; Brenda W Gillespie; Debbie S Gipson; Chia-Shi Wang; Afshin Parsa; Lisa Guay-Woodford; Louis-Philippe Laurin
Journal:  Kidney Int Rep       Date:  2019-09-16

Review 7.  Membranous nephropathy in children: clinical presentation and therapeutic approach.

Authors:  Shina Menon; Rudolph P Valentini
Journal:  Pediatr Nephrol       Date:  2009-11-12       Impact factor: 3.714

8.  Membranous nephritis associated with acquired cytomegalovirus infection in a 19-month-old baby.

Authors:  Helen Georgaki-Angelaki; Lilia Lycopoulou; Nicolaos Stergiou; Despina Lazopoulou; Helen Paraskevakou; Maria Giannaki-Psinaki; Andreas Mentis
Journal:  Pediatr Nephrol       Date:  2008-09-04       Impact factor: 3.651

9.  Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.

Authors:  Ashton Chen; Rachel Frank; Suzanne Vento; Virginia Crosby; Manju Chandra; Bernard Gauthier; Elsa Valderrama; Howard Trachtman
Journal:  BMC Nephrol       Date:  2007-08-06       Impact factor: 2.388

10.  Chapter 7: Idiopathic membranous nephropathy.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.